Bucci, Tommaso http://orcid.org/0000-0003-2895-6234
Sagris, Dimitrios
Harrison, Stephanie L.
Underhill, Paula
Pastori, Daniele
Ntaios, George
McDowell, Garry
Buckley, Benjamin J. R.
Lip, Gregory Y. H.
Article History
Received: 24 November 2022
Accepted: 14 April 2023
First Online: 29 April 2023
Declarations
:
: Dr. Bucci reports no disclosures; Dr. Sagris reports receiving research support by the ESC council on Stroke; Dr Harrison has received a grant from Bristol-Myers Squibb (BMS) outside of the submitted work; Dr Underhill is an employee of TriNetX LLC; Prof. Pastori reports no disclosures; Prof. Ntaios: none related; Dr. McDowell: has received funding and research support from Roche Diagnostics and Abbott; Dr. Buckley: Research funding from BMS/Pfizer; Prof. Lip: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim and Daiichi-Sankyo. No fees are received personally. GYHL is co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 899871.
: TriNetx is a research network utilized for several scientific purposes, compliant with the Health Insurance Portability and Accountability Act and the US federal law which protects the privacy and security of healthcare data, including de-identified data as per the de-identification standard of the HIPAA Privacy Rule(ExternalRef removed). To gain access to the data in the TriNetX research network, requests are directed to TriNetX and a data sharing agreement is required. As a federated research network, studies using the TriNetX health research network do not need ethical approval as no patient identifiable identification is received. Further information about the data extraction from TriNetX is reported in the supplementary material.